IOL Chemicals And PharmaceuticalsNSE:IOLCP -4.89%69 Return-on-Tangible-Asset is 8.27% as of Mar. 2026, which is 24% above its 10-year median of 6.67. GuruFocus rates NSE:IOLCP with a GF Score™ of 69/100 and a GF Value™ of ₹93.85 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 1,003 Drug Manufacturers companies, IOL Chemicals And Pharmaceuticals ranks better than 61.91% on this metric.
The historical rank and industry rank for IOL Chemicals And Pharmaceuticals's Return-on-Tangible-Asset or its related term are showing as below:
NSE:IOLCP'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 0.59 Med: 6.67 Max: 34.24
Current: 5.63
During the past 13 years, IOL Chemicals And Pharmaceuticals's highest Return-on-Tangible-Asset was 34.24%. The lowest was 0.59%. And the median was 6.67%.
NSE:IOLCP's Return-on-Tangible-Asset is ranked better than 61.91% of 1003
companies
in the Drug Manufacturers industry
Industry Median: 3.15
vs NSE:IOLCP: 5.63
IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
IOL Chemicals And Pharmaceuticals Return-on-Tangible-Asset Related Terms
IOL Chemicals And Pharmaceuticals Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IOL Chemicals And Pharmaceuticals Return-on-Tangible-Asset Chart
NSE:IOLCP vs ZTS, UTHR: Return-on-Tangible-Asset Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, IOL Chemicals And Pharmaceuticals's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IOL Chemicals And Pharmaceuticals Return-on-Tangible-Asset vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, IOL Chemicals And Pharmaceuticals's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where IOL Chemicals And Pharmaceuticals's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 8.27% mean?
IOL Chemicals And Pharmaceuticals (NSE:IOLCP) has a Return-on-Tangible-Asset of 8.27% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on IOL Chemicals And Pharmaceuticals and its competitors. This is 24% above median its historical median of 6.67. Over the past decade, IOL Chemicals And Pharmaceuticals' Return-on-Tangible-Asset has ranged from 0.59 to 34.24. According to the industry distribution chart, IOL Chemicals And Pharmaceuticals ranks #382 out of 1003 companies in the Drug Manufacturers industry, placing it in the top 38.1%.
Is IOL Chemicals And Pharmaceuticals' Return-on-Tangible-Asset too high?
IOL Chemicals And Pharmaceuticals' current Return-on-Tangible-Asset of 8.27% is 24% above median its 10-year median of 6.67. Over the past 10 years, this metric has ranged from a low of 0.59 to a high of 34.24. The Drug Manufacturers industry median Return-on-Tangible-Asset is 3.15. IOL Chemicals And Pharmaceuticals' value of 8.27% is 162.5% above this industry median. Based on the distribution chart, IOL Chemicals And Pharmaceuticals ranks #382 out of 1003 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, IOL Chemicals And Pharmaceuticals has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IOL Chemicals And Pharmaceuticals' Return-on-Tangible-Asset compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, IOL Chemicals And Pharmaceuticals ranks #382 out of 1003 companies for Return-on-Tangible-Asset. This puts IOL Chemicals And Pharmaceuticals in the upper half of its industry. The industry median Return-on-Tangible-Asset is 3.15. IOL Chemicals And Pharmaceuticals' value of 8.27% is 162.5% above this benchmark. Historically, IOL Chemicals And Pharmaceuticals' own Return-on-Tangible-Asset has ranged from 0.59 to 34.24 over the past decade. While the company's 10-year median is 6.67 vs. the industry median of 3.15, IOL Chemicals And Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Drug Manufacturers company?
The median Return-on-Tangible-Asset among Drug Manufacturers companies is 3.15, based on 1,003 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IOL Chemicals And Pharmaceuticals's current Return-on-Tangible-Asset of 8.27% is 162.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on IOL Chemicals And Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Return-on-Tangible-Asset is 3.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IOL Chemicals And Pharmaceuticals's current Return-on-Tangible-Asset is 8.27%, which is 24% above median its own 10-year median of 6.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IOL Chemicals And Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals (NSE:IOLCP) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹93.85, compared to a current price of ₹142.96 — trading 52.3% above its estimated fair value. The current Return-on-Tangible-Asset is 8.27%, which is 24% above median its 10-year median of 6.67 and 162.5% above the Drug Manufacturers industry median of 3.15. IOL Chemicals And Pharmaceuticals' overall GF Score™ is 69/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For IOL Chemicals And Pharmaceuticals (NSE:IOLCP), the current Return-on-Tangible-Asset is 8.27% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Overvalued in 2026?
Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals stock appears to be overvalued.
The current stock price of ₹142.96 is trading 52.3% above its estimated GF Value™ of ₹93.85.
GuruFocus considers IOL Chemicals And Pharmaceuticals to be Significantly Overvalued.
Key valuation signals for NSE:IOLCP:
Return-on-Tangible-Asset: 8.27% (24% above median its 10-year median of 6.67)
GF Value™: ₹93.85 vs. price of ₹142.96 (52.3% above fair value)
Industry Position: 162.5% above the Drug Manufacturers median (#382 of 1003)
No single metric tells the full story. See the NSE:IOLCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IOL Chemicals And Pharmaceuticals Business Description
IOL Chemicals And Pharmaceuticals Ltd is an India-based pharmaceutical company. The primary activity of the group is the manufacturing and sale of drugs and organic chemicals. The business activity is functioned through the Chemicals and Pharmaceutical segments. The Chemicals segment produces and sells chemicals such as Ethyl Acetate, Acetic Anhydride, Acetyl Chloride, Mono Chloro Acetic Acid, and Iso Butyl benzene, whereas the Pharmaceutical segment produces and sells various active pharmaceutical ingredients such as Ibuprofen, Metformin, Fenofibrate, Lamotrigine, and others. It derives prime revenue from the Pharmaceutical segment. Geographically, the group's products are sold in both the Indian and international markets.
69GF Score
Get the complete analysis for NSE:IOLCP
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:IOLCP has been successfully added to your 
